Return to content in this issue

Allergen Immunotherapy in the Era of SARS-CoV-2

Compalati E¹, Erlewyn-Lajeunesse M², Runa Ali F³, Ojeda Fernández P⁴, Garcia Nuñez I^5,6, Frati F¹, Mistrello G<sup>1

1</sup>Lofarma Scientific Department, Lofarma S.p.A., Milan
²Paediatric Allergy & Immunology, Southampton Children’s Hospital, Southampton, UK
³Barts Health NHS Trust, London, UK
⁴Clínica de Asma y Alergia Dres. Ojeda, Madrid, Spain
⁵Hospital Quirónsalud, Córdoba, Spain
⁶Hospital Quirónsalud, Campo de Gibraltar, Palmones, Spain

J Investig Allergol Clin Immunol 2020; Vol 30(6) : 459-461
doi: 10.18176/jiaci.0568